Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study (Q35212898)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

7 August 2017

Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study (English)

1 reference

Europe PubMed Central

7 August 2017

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

9

object named as

Alain Tedgui

1 reference

Europe PubMed Central

7 August 2017

3

object named as

Ziad Mallat

1 reference

Europe PubMed Central

7 August 2017

Joseph L Witztum

10

object named as

Joseph L Witztum

1 reference

Europe PubMed Central

7 August 2017

Philippa Talmud

object named as

Philippa J Talmud

4

0 references

Nicholas J. Wareham

6

object named as

Nicholas J Wareham

1 reference

Europe PubMed Central

7 August 2017

11

object named as

Kay-Tee Khaw

1 reference

Europe PubMed Central

7 August 2017

Sotirios Tsimikas

12

object named as

Sotirios Tsimikas

1 reference

Europe PubMed Central

7 August 2017

John J. P. Kastelein

5

object named as

John J P Kastelein

1 reference

Europe PubMed Central

7 August 2017

1

object named as

Amir Ravandi

1 reference

Europe PubMed Central

7 August 2017

S Matthijs Boekholdt

2

object named as

S Matthijs Boekholdt

1 reference

Europe PubMed Central

7 August 2017

Joelle Benessiano

8

object named as

Joelle Benessiano

1 reference

Europe PubMed Central

7 August 2017

author name string

Elizabeth R Miller

7

1 reference

Europe PubMed Central

7 August 2017

publication date

5 August 2011

1 reference

Europe PubMed Central

7 August 2017

Journal of Lipid Research

1 reference

Europe PubMed Central

7 August 2017

52

1 reference

Europe PubMed Central

7 August 2017

10

1 reference

Europe PubMed Central

7 August 2017

1829-1836

1 reference

Europe PubMed Central

7 August 2017

Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: roles as biological effectors and biomarkers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

Clinical significance of the humoral immune response to modified LDL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

28 July 2018

Oxidized low-density lipoprotein and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

The role of innate immunity in atherogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

26 September 2018

Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173004

8 December 2018

Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21821825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21821825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21821825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody against oxidized low-density lipoprotein predicting myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21821825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21821825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy with interleukin-2 induces the systemic release of phospholipase-A2

1 reference

https://pubmed.ncbi.nlm.nih.gov/21821825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21821825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies to OxLDL are decreased in individuals with borderline hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/21821825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21821825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21821825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphorylcholine-targeting immunization reduces atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21821825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21821825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1194/JLR.M015776

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35212898&oldid=1858276138"